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Abstract 
The SMC protein complexes play important roles in chromosome dynamics. The 
function of the SMC5-6 complex remains unclear, though it is involved in resolution 
of different DNA structures by recombination.  We have now identified and 
characterised the four non-SMC components of the human complex and in particular 
demonstrated that the MAGEG1 protein is part of this complex. MAGE proteins play 
important but as yet undefined roles in carcinogenesis, apoptosis and brain 
development. We show that, with the exception of the SUMO ligase 
hMMS21/hNSE2, depletion of any of the components results in degradation of all the 
other components. Depletion also confers sensitivity to methyl methanesulfonate. 
Several of the components are modified by sumoylation and ubiquitination. 
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Introduction 
SMC (Structural Maintenance of Chromosomes) proteins form the cores of three 
essential protein complexes involved in important aspects of chromosome dynamics 
(see (15) for review). Cohesin, containing Smc1 and 3, is the molecular glue that 
holds sister chromatids together from the time that they are established during DNA 
replication until they separate in anaphase. Smc2 and 4 form the core of condensin, 
which plays a crucial role in compaction of chromosomes at the beginning of mitosis. 
The function of the SMC5-6 complex is less clear, but it has an important role in a 
variety of different DNA repair processes and in resolving recombination structures. 
 
The SMC proteins are conserved throughout eukaryotes and all have similar 
structures. Globular domains at the N- and C-termini are separated by two long 
coiled-coil domains linked together by a hinge. Each SMC protein is doubled back at 
the hinge region such that the coiled coil domains interact with each other in an 
antiparallel manner and the globular domains are brought together. In this way a 
Walker A motif in the N-terminal domain and a Walker B motif in the C-terminal 
domain are juxtaposed to generate a globular ATP binding and hydrolysis “head” 
domain. The two Smc proteins in each complex interact with each other via the hinge. 
In cohesin the head domains of Smc1 and Smc3 are also brought together with the 
non-Smc components to form a ring, which is thought to encircle the two sister 
chromatids. It is not known if the other Smc complexes also form such a ring 
structure. 
 
The rad18 gene of Schizosaccharomyces pombe was isolated as a mutant sensitive to 
both UV and ionising radiation. It was subsequently found to encode an SMC protein 
(12) that was redesignated Smc6 as part of the SMC5-6 complex. Further genetic and 
biochemical studies revealed a role in the repair of double-strand breaks as well as in 
other repair processes involving repair by homologous recombination (12, 29). The 
precise function remains unclear. The SMC5-6 complex is essential for cell 
proliferation, but cells are still able to go through several rounds of division in the 
absence of Smc6 (9). This suggests that death might result from an accumulation of 
unrepaired damage. Recent work has shown an accumulation of SMC5-6 at rDNA 
and telomeres and that segregation of rDNA at anaphase is aberrant in temperature-
sensitive mutants of SMC6 in Saccharomyces cerevisiae (28). Furthermore, although 
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gross DNA replication was unaffected in a temperature-sensitive smc6 mutant, the 
ability to resolve replicated chromatids was defective (13). Following treatment of S. 
cerevisiae with methyl methane sulfonate, 2-D gel analysis reveals the accumulation 
of X-like structures in smc5-6 mutants (5). Also in S. pombe smc6 mutants are unable 
to rescue collapsed replication forks (1). Taken together, these data suggest a role for 
SMC5-6 in the resolution of complex structures by homologous recombination. 
 
Aside from the Smc5 and Smc6 proteins that form the core of the S. pombe SMC5-6 
complex, there are four essential non-Smc proteins, designated Nse1-4 (8, 9, 16, 17, 
21, 26), and two further proteins Nse5 and 6 that are not essential for proliferation 
(22). In contrast in S. cerevisiae all six non-SMC proteins are essential (10, 30).  
 
Nse1 has a RING finger typical of E3 ubiquitin ligases, but evidence for E3 activity 
has so far not been reported. Nse2 is a Sumo ligase, which binds to Smc5, but in S. 
pombe it sumoylates Smc6, and this sumoylation is stimulated by DNA damage (2). 
Mutations that abolish the sumoylation activity confer sensitivity to DNA damage, but 
do not affect the essential function of the SMC5-6 complex (2). Similar results were 
obtained with Mms21, the ortholog from S. cerevisiae (30), although in S. cerevisiae, 
the substrate appeared to be Smc5. Nse3 is related to the MAGE family of proteins (7) 
and Nse4 is a member of the kleisin superfamily (20). The kleisins are thought to 
bridge the head domains of the Smc proteins (25), and we have shown that Nse4 is 
indeed able to bind the heads of Smc5 and Smc6 (20). Nse6 contains ARM/HEAT 
repeats but there is no sequence conservation between these presumed orthologs from 
S. cerevisiae and S. pombe. In S. pombe they also appear to bridge the head domains 
of Smc5 and Smc6 (20, 22). Although all these proteins appear to form a single tight 
complex inside cells (22, 26, 30), attempts to reassemble the complex from individual 
polypeptides have identified three sub-complexes, namely Smc6-Smc5-Nse2, Nse1-
Nse3-Nse4 and Nse5-Nse6 (22, 26).  
 
In previous work we characterised the SMC5 and SMC6 proteins from human and 
mouse cells (27). We showed that they interact in human cells and that the interaction 
is mediated by the hinge regions and abolished by mutation of a single conserved 
glycine residue in the hinge region of either hSMC5 or hSMC6 (26). mSMC5 and 6 
are expressed in all tissues and localise to the sex vesicle during meiosis (27). Others 
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have identified human orthologs of Nse1 (9) and Nse2 (24), and the human NSE2 
ortholog (hMMS21) has been extensively characterised (23, 24). However there are 
two human homologs of Nse4 in the sequence databases and 55 human proteins 
containing MAGE domains. In this paper we describe the characterisation of the 
mammalian NSE proteins. In particular, we show that both NSE4 paralogs can form 
part of the complex, but only one of them is expressed in somatic cells, we identify 
MAGE-G1 as the ortholog of Nse3, we show that all the components form a tight 
complex and that some of them are modified by ubiquitylation or sumoylation. 
Finally, we show that knockdown of hNSE1 or hNSE4a confers sensitivity to methyl 
methanesulfonate (MMS). 
 
Materials and Methods 
Plasmids 
DNA sequences encoding the open reading frames (ORFs) of hNSE1, hNSE4a, 
MAGEG1 and MAGEF1 were acquired from the IMAGE consortium. 
hMMS21/hNSE2, hNSE4b and SUMO1 ORFs were amplified by PCR from human 
cDNA generated from 1BR.3 primary human fibroblasts using the First Strand cDNA 
Synthesis kit (GE Healthcare). hNSE1 cDNA starting at Met2  (see Figure 1A) was 
amplified from the IMAGE clone. To make the longer clone starting at Met1, approx 
110 nucleotides of cDNA upstream of Met2 was amplified by PCR from human 
genomic DNA and ligated to the construct starting at Met2.  
Full length ORFs were subcloned into various vectors for different expression 
purposes: pEPEX was used for in vitro transcription/translation using the TNT Quick 
Coupled Transcription/Translation System (Promega); pCI-neo (Promega) 
incorporating FLAG, myc, 10x His and/or GFP tags were used for expression in 
mammalian cells; pQE30 (Qiagen) was used for expression of 6x His-tagged 
recombinant protein and pGEX-KG was used for expression of glutathione-S-
transferase (GST) tagged recombinant protein in E. coli.  
 
Antibodies 
Full length hNSE1, hNSE4a and MAGEG1 were expressed in E.coli as N-terminally 
hexahistidine-tagged fusion proteins. The proteins were each purified to near 
homogeneity under denaturing conditions by Ni2+-nitrilotriacetic acid (Ni2+-NTA) 
affinity chromatography and then used to inoculate two rabbits for antibody 
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generation (Eurogentec). Full length hMMS21/hNSE2 was expressed in bacteria as a 
GST fusion, purified on glutathione sepharose (GE Healthcare) according to the 
manufacturer’s instructions and used for antibody production. hNSE1 and 
hMMS21/hNSE2 antibodies were affinity purified using antigen immobilised with 
Aminolink Plus Coupling Gel (Pierce). Antibodies to MAGEG1 and hNSE4a were 
affinity purified using antigen that had been transferred to nitrocellulose membrane. 
hSMC5 and hSMC6 antibodies have been described previously (27). Anti-FLAG M2 
(Sigma-Aldrich) and anti-vimentin (Oncogene) commercial antibodies were also used 
in this study. 
 
Immunoblotting and immunoprecipitation 
For immunoblotting MRC5V1 cells were lysed in SDS sample buffer, sonicated, 
boiled and the proteins resolved by SDS-PAGE. Proteins were transferred to 
nitrocellulose membrane (GE Healthcare) and blotted with appropriate primary 
antibodies followed by secondary HRP-conjugated goat anti-rabbit antibody (DAKO) 
or HRP-conjugated rabbit anti-mouse antibody (DAKO). Proteins were visualised 
using Western Lightning chemiluminescent detection reagent (Perkin-Elmer) 
according to the manufacturer’s instructions. 
For immunoprecipitation of FLAG-tagged proteins, whole cell extracts were made by 
lysing cells in lysis buffer (20mM Hepes, pH7.9, 20mM NaCl, 1mM MgCl2, 0.5% 
Triton X-100, 1μl/ml benzonase (Merck) and 1x complete EDTA-free protease 
inhibitor mix (Roche)) at 25°C for 10 min followed by incubation on ice for 10 min. 
One volume of extraction buffer (20mM Hepes, pH7.9, 0.5M NaCl, 0.2mM EDTA, 
20% glycerol, 0.5mM DTT and 1x complete EDTA-free protease inhibitor mix) was 
added and the extract held on ice for 15 min before the addition of eight volumes of 
dilution buffer (20mM Hepes, pH7.9, 100mM NaCl, 0.2mM EDTA, 10% glycerol, 
0.5mM DTT and 1x complete EDTA-free protease inhibitor mix). Extracts were 
cleared by centrifugation at 13,000 rpm for 5 min and soluble fractions were mixed 
with anti-FLAG M2 antibody and protein G sepharose beads (CRUK, London) 
overnight at 4°C. The beads were washed once with wash buffer 1 (20mM Hepes, 
pH7.9, 0.5M NaCl, 0.2mM EDTA, 0.5mM DTT and 0.1% Triton X-100) and three 
times with wash buffer 2 (20mM Hepes, pH7.9, 1M NaCl, 0.2mM EDTA, 0.5mM 
DTT and 0.1% Triton X-100) then resuspended and boiled in SDS sample buffer. 
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Endogenous proteins were immunoprecipitated from either commercially prepared 
HeLa cell nuclear extract (4C, Belgium) or from whole cell extracts prepared from 
MRC5V1 cells as described above. Cleared extracts were incubated for 4 h or 
overnight with protein A sepharose beads that had been previously crosslinked to 
either anti-hSMC6 antibodies, anti-hNSE1antibodies or non-specific rabbit IgGs 
using dimethylpimelimidate. The beads were washed two times with wash buffer 1 
and three times with wash buffer 2, resuspended and boiled in SDS sample buffer. 
Immunoprecipitated samples were resolved on SDS-PAGE and analysed by blotting 
with appropriate antibodies. For detection of immunoprecipitated proteins a protein 
A-HRP conjugate (Pierce) was routinely used in place of secondary antibody in order 
to reduce problems with IgG heavy and light chains masking proteins of interest at the 
same molecular weight. 
 
Mass spectrometric analysis of SMC5/6 associated proteins 
The hSMC5/6 complex was purified from HeLa cell nuclear extract (4C, Belgium) by 
anion exchange chromatography followed by immunoprecipitation with anti-hSMC6 
or anti-hNSE1 antibody beads. Briefly, HeLa cell nuclear extract (60mg) was cleared 
by centrifugation (18,000 rpm, 30 min) and applied to a Mono Q anion exchange 
column. Fractions containing hSMC5/6 following elution with a salt gradient were 
then diluted two-fold with 20mM Hepes, pH7.9, 0.2mM EDTA, 10% glycerol, 
0.5mM DTT and 1x complete EDTA-free protease inhibitor mix and 
immunoprecipitated as described above. The hSMC5/6 complex was eluted from the 
antibody beads using 200mM glycine pH2.5 then precipitated with four volumes of 
acetone. Following reduction and alkylation, proteins were digested with 25ng/ ul 
trypsin for 16h at 37°C. The resulting peptide mixture was diluted in 0.1% TFA for 
analysis by nanoLC-MS/MS at the Sussex Centre for Proteomics using an LTQ linear 
ion trap (Thermo Fisher). Proteins were identified by automated database searching 
against the NCBI human protein sequence database using the SEQUEST  algorithm as 
implemented in Bioworks v 3.1 (Thermo Fisher). Filtering criteria for positive protein 
identifications were the detection of at least two fully tryptic peptides with Xcorr 
values greater than  1.9 for +1 spectra, 2.2 for +2 spectra and 3.5 for +3 spectra, and a  
delta Cn of greater than 0.1. 
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Size exclusion chromatography 
For gel filtration analysis HeLa cell nuclear extract was diluted two-fold with buffer 
A (20mM Hepes, pH7.9, 150mM KCl, 0.2mM EDTA, 0.5mM DTT and 1x complete 
EDTA-free protease inhibitor mix) and cleared by centrifugation (20,000 rpm, 10 
min). Proteins (2mg) were loaded onto a Superdex 200 column and 0.5ml fractions 
were collected. Proteins in each fraction were acetone precipitated, dissolved in SDS 
sample buffer, resolved on SDS-PAGE and analysed by Western blotting. 
 
Nickel-NTA pulldowns 
For nickel-NTA pulldown experiments extracts were made, 24h after transfection 
with the appropriate plasmids, by briefly sonicating cells in Ni2+-NTA lysis buffer 
(50mM Tris, pH7.5, 150mM NaCl, 0.1% SDS, 0.5% Triton X-100, 20mM imidazole, 
4mM N-ethylmaleimide and 1x complete EDTA-free protease inhibitor mix). Extracts 
were cleared by centrifugation (13,000 rpm, 5 min) and diluted with 5 volumes of 
Ni2+-NTA dilution buffer (50mM Tris, pH7.5, 150mM NaCl, 0.1% Triton X-100, 
20mM imidazole, 4mM N-ethylmaleimide and 1x complete EDTA-free protease 
inhibitor mix) then mixed with Ni2+-NTA agarose (Qiagen) for 3h. The beads were 
washed five times with Ni2+-NTA dilution buffer, resuspended in SDS sample buffer 
and bound proteins analysed by Western blotting. 
 
Cell culture and transfection 
SV40-transformed MRC5 cells (designated MRC5V1) were grown in Eagle’s MEM 
(Invitrogen) supplemented with 10% foetal bovine serum (Invitrogen) and 100μg/ml 
penicillin and streptomycin (Invitrogen). Plasmid transfections were performed using 
Fugene (Roche) according to the manufacturer’s instructions. For stable transfectants, 
MRC5V1 cells were transfected with pCI-neo-derived plasmids and selection (800 
μg/ml G418) was applied 48h after transfection. Stable transfectants were isolated 
after 2 weeks.  
 
siRNA techniques 
siRNA oligonucleotides were obtained from Qiagen (Table 1). siRNA transfections 
were performed at 60-70% confluency using HiPerfect transfection reagent (Qiagen) 
according to the manufacturer’s instructions. To determine the efficiency of RNAi 
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knockdown, siRNA-transfected cells were lysed (3-4 days post-transfection) in 50mM 
Tris, pH 7.5, 150mM NaCl, 1mM MgCl2, 0.1% SDS and 1μl/ml benzonase at 25°C 
for 10 min. Extracts were cleared by centrifugation (13,000 rpm, 5 min), boiled in 
SDS sample buffer and analysed by Western blotting. MMS sensitivity was 
determined 96h after siRNA transfection by adding MMS at the indicated doses (0 – 
0.0075%) for 1h. The cells were then washed free of the drug and plated for colony 
formation. Colonies were counted 12 days later. 
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Results 
hNSE1 and hMMS21/hNSE2 
A human ortholog of Nse1 (hNSE1, NMSCE1) has been identified by several groups 
(8, 9, 24). However the start site proposed by Fujioka et al (8) (MQGS.., indicated 2 
in Figure 1A) is 10 aa upstream of that proposed by Harvey et al (9) (MTDV..., 
indicated 4 in Figure 1A) and the ten intervening aa are highly conserved in mammals 
(Figure 1A). Comparison of the hNSE1 sequences in the EST database with the 
genomic sequence identifies an intron four aa upstream of the MQGS sequence and 
an ORF extending to a methionine a further 33 aa upstream (indicated 1 in Figure 
1A). Conservation of the predicted amino acids translated from this upstream exon is 
poor, with significant sequence identity found only among primates (Figure 1A). In 
contrast the rest of the sequence is highly conserved among mammals (not shown). In 
order to determine the actual translation start site, we generated an antibody against 
hNSE1. We then cloned hNSE1 cDNA into an expression vector, starting from either 
methionine 1 (as shown in Fig 1A) or from methionine 2 and expressed the inserted 
protein using in vitro transcription-translation. Using the shorter construct, the 
antibody detected two bands (Figure 1B, left panel, lane 1), which we interpret to 
represent initiation from methionines 2 and 4 respectively. With the longer construct, 
we obtained the same doublet and in addition a faint band of higher molecular weight, 
which we interpret as protein initiated from methionine 1 (lane 2). To confirm this 
interpretation, we used the construct starting from methionine 1 and mutated each of 
methionines 1, 2 and 4 to alanine. We found that the predicted bands disappeared, ie 
the top, middle and bottom bands disappeared, if we mutated methionines 1, 2 and 4 
respectively (Figure 1B, right panel, lanes 5-7). Thus the major initiating ATGs are 
methionines 2 and 4, and methionine 1 is rarely used. Consistent with this, when we 
examined human cell extracts by immunoblotting with the anti-hNSE1 antibody, we 
again obtained a doublet, corresponding to initiation at methionines 2 and 4, the 
former being the stronger band (Figure 1B, lanes 3 and 8). We conclude that the 
major initiation site is at methionine 2 (MQGS). 
 
To see if hNSE1 interacts with hSMC6, we immunoprecipitated endogenous hSMC6 
from MRC5 cell extracts and analysed the immunoprecipitates. Figure 1C shows that 
anti-hSMC6 pulls down hNSE1 (lane 4) and conversely immunoprecipitation with 
anti hNSE1 pulls down hSMC6 (lane 6). We note that in the immunoprecipitation 
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with anti-hSMC6, some hNSE1 remains unbound (lane 3), whereas anti-hNSE1 
quantitatively immunoprecipitates hSMC6 (compare lane 5). This suggests that some 
hNSE1 protein is not associated with the complex (see below for further discussion). 
 
hNSE2 (hMMS21, NSMCE2), the human homolog of Nse2 in S. pombe and Mms21 
in S. cerevisiae has been identified and characterised by Potts et al (23, 24). They 
showed that hMMS21/hNSE2 co-immunoprecipitated with hSMC5. We have raised 
an antibody against hMMS21/hNSE2, which is specific as it identifies a band from 
hMMS21/hNSE2 generated by in vitro transcription/translation (Fig 1D, lane 2), and 
a band of identical size from human cell extracts (lane 3). hMMS21/hNSE2 is pulled 
down in immunoprecipitations with anti-hSMC6 and anti-hNSE1 (Fig 1E), 
confirming that it is part of the SMC5-6 complex in human cells. 
 
hNSE4 
We previously showed, as suggested by Nasmyth and Haering (18), that the predicted 
structure of S. pombe Nse4 was similar to that of the kleisin superfamily, members of 
which bridge the heads of SMC proteins. Consistent with this idea we found that the 
C-terminal half of Nse4 interacted with Smc5 and that Nse4 also interacted with 
Smc6 (20). There are two human homologs of Nse4 in the sequence databases. The 
first of these (NSMCE4A; C10orf86) is on chromosome 10 (Accession no. 
Q9NXX6). The second is identical to a protein designated  E1A-like inhibitor of 
differentiation 3 (EID3) on chromosome 12 (4) and appears to be a transcriptional 
repressor. 
 
We will refer to these as hNSE4a and hNSE4b respectively. These sequences are 
approximately 50% identical to each other and each is approximately 25% identical to 
S. pombe Nse4 (Figure 2A). Sequence similarity is highest in the two regions that we 
previously identified as conserved helix-turn-helix and winged helix domains 
respectively (20). hNSE4b/EID3 is expressed exclusively in testis (4), whereas the 
ESTs from hNSE4a were derived from many different tissues. We transfected FLAG-
tagged constructs of each paralog into MRC5 cells and immunoprecipitated them 
from cell extracts with anti-FLAG antibody. Immunoblotting revealed the presence of 
both hSMC6 and hNSE1 in each of the immunoprecipitates (Fig 2B and C), 
suggesting that both paralogs could be incorporated into the SMC5-6 complex. 
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 MAGEG1 
NSE3 is related to the MAGE family of proteins. There are 55 MAGE genes in the 
human genome, which have been subdivided into different classes, based on their 
protein structures (3, 7). Many of them are expressed only in tumour cells or in the 
germ line. To identify the MAGE protein in the SMC5-6 complex, we 
immunoprecipitated the complex with antibodies to either hNSE1 or hSMC6. We 
subjected the two immunoprecipitates, without further fractionation, to mass 
spectroscopy to identify proteins that were present in both immunoprecipitates. We 
were able to identify hSMC5, hSMC6, hNSE1, 2 and 4a and one member of the 
MAGE family, MAGEG1 (Table 2).  
 
MAGEG1 (NDNL2) maps to chromosome 15q close to the autistic disorder 
susceptibility region, but is not thought to be involved in these disorders (6). It is 
expressed in all tissues and is closely related to MAGEF1 (3, 7). We therefore FLAG-
tagged both MAGEG1 and MAGEF1 and expressed them in MRC5 cells. 
Immunoprecipitation with anti-FLAG followed by immunoblotting showed that 
MAGEG1 was able to co-immunoprecipitate hNSE1 and hSMC6 from cell extracts 
(Figure 2D, lane 5), whereas they were not precipitated by MAGEF1 (Figure 2D, lane 
6). These results indicate that MAGEG1 is the human ortholog of NSE3. There is 
20% sequence identity between these orthologs. 
 
Composition and stability of the complex 
To confirm the composition of the complex, we immunoprecipitated cell extracts with 
either anti-hNSE1 or anti-hSMC6 antibodies in 1M-NaCl. Both of the 
immunoprecipitated complexes contained hSMC5, hSMC6, hNSE4a, MAGEG1, 
hMMS21/hNSE2 and hNSE1 (Fig 3A, lanes 2, 3). These data demonstrate that these 
six proteins form a stable complex in human cells.  
 
Interestingly, the anti-hSMC6 immunoprecipitates contained essentially all of the 
hSMC5, hMMS21/hNSE2 and hNSE4a in the extracts. None of these proteins 
remained in the supernatant. MAGEG1 and hNSE1 were found in both unbound and 
bound fractions. Similarly, the anti-hNSE1 immunoprecipitates quantitatively bound 
all the other components. These data suggest that, with the exception of MAGEG1 
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and hNSE1, the hSMC5-6 components are present exclusively in the complex. To 
obtain independent evidence to support this conclusion, soluble extracts were 
analysed by gel filtration and immunoblotting (Figure 3B). A large proportion of each 
component was present in fractions corresponding to a globular protein of approx 800 
kDa. In the case of hSMC5, hSMC6, hNSE4a and hMMS21/hNSE2, almost all of the 
protein was in this high mol wt complex with a small amount spread through the 
following few fractions. In the case of MAGEG1 there was a small amount at lower 
molecular weight and in the case of hNSE1, there were two smaller protein peaks. 
Thus most of the proteins are present in the hSMC5-6 complex with little free protein 
in the extracts.  
 
To examine if all the proteins were necessary to maintain the stability of the complex, 
we developed siRNAs against most of the identified components (Table 1). As can be 
seen from Figure 3C, transfection of MRC5 human fibroblasts with any of the 
siRNAs reduced the concentration of the corresponding proteins by >80%. 
Furthermore, knock-down of hSMC5, hNSE4a, MAGEG1 or hNSE1 (lanes 2-5) also 
reduced the concentration of the other components, with the exception of 
hMMS21/hNSE2, which was somewhat reduced but not as drastically as the other 
components. Conversely knock-down of hMMS21/hNSE2 had little effect on the 
concentration of any of the other components (lane 6). These results suggest that all 
the components except for hMMS21/hNSE2 are necessary for the stability of the 
complex, and in the absence of the complex, the protein components are degraded. 
hMMS21/hNSE2 appears to be the only protein that remains stable in the absence of 
the others. 
 
DNA damage responses 
To examine the biological effect of reducing the levels of SMC5-6 components, we 
treated MRC5 cells with the siRNAs described above and then exposed the cells to 
different DNA damaging agents. We found no significant effect on colony-forming 
ability after treatment with UV- or γ-irradiation, or treatment with mitomycin C. 
Sensitivity to MMS was observed when either hNSE1 or hNSE4a were knocked down 
(Fig 3D). 
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Post-translational modifications 
hNSE1 has a RING finger motif characteristic of E3 ubiquitin ligases and 
hMMS21/hNSE2 is a SUMO ligase. As a first step in identifying possible targets of 
these proteins, we checked to see if any of the components are themselves modified 
by ubiquitin or Sumo. We co-transfected cells with myc-tagged hMMS21/hNSE2 and 
SUMO1 tagged with either His, GFP or GFP-His. Lysates were analysed by 
immunoblotting with anti-hMMS21/hNSE2 antibody (Figure 4A), either directly 
(lanes 1-4) or after extraction on nickel-agarose (lanes 5-8). In both samples in which 
the SUMO1 had a His-tag, specific bands corresponding to sumoylated 
hMMS21/hNSE2 were detected (lanes 2, 4, 6, 8). A much stronger band was obtained 
with GFP-His SUMO1-tagged samples (lanes 4, 8). 
 
In a similar experiment with GFP-his-tagged SUMO-1, the lysates were analysed for 
modified forms of either hSMC5 or hSMC6. Figure 4B shows that high molecular 
weight species representing sumoylated hSMC5 (top panel, lanes 2, 4, 6) and SMC6 
(bottom panel, lanes 2, 4, 6) were detected specifically in those cells which had been 
transfected with GFP-his-tagged SUMO-1. The intensity of this higher molecular 
weight band was not affected by overexpression of hMMS21/hNSE2 or by treatment 
of cells with MMS. There was no evidence for sumoylation of hNSE1, MAGEG1 or 
hNSE4a (data not shown). Note that unexpectedly we found bands corresponding to 
unmodified hSMC5, SMC6 and Myc-HMMS21/hNSE2 binding to nickel beads. We 
have found in many experiments that several members of the complex have affinity 
for nickel beads even without His tags. 
 
In analogous experiments to look for ubiquitinated species, MRC5 cells were 
transfected with FLAG-hNSE1 and his-tagged ubiquitin. Cells were lysed under 
denaturing conditions and the lysates extracted with Ni-agarose beads and analysed 
by immunoblotting with anti-hNSE1 antibody. Strong bands corresponding to 
ubiquitinated species of hNSE1 were detected in these extracts (Figure 5A, lane 4) but 
not in cells which were transfected with FLAG-tagged hNSE1 (lane 2) or his-tagged 
ubiquitin (lane 3) alone. In subsequent experiments, ubiquitylation of  endogenous 
hNSE1 was analysed by transfecting cells with His-tagged ubiquitin, extracting on 
nickel and probing with anti-HNSE1 antibody. High molecular weight species were 
detected in cells cotransfected with His-Ubiquitin, but not in cells transfected with 
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empty vector (Figure 5B). We were similarly able to identify ubiquitinated species of 
SMC5 and 6 in cells transfected with His-ubiquitin (Figure 5C). The ubiquitylated 
species were not affected by treatment of the cells with MMS. 
 
Discussion 
The SMC5-6 complexes in S. cerevisiae and S. pombe contain eight components. 
These are Smc5 and 6 and six non-SMC components, Nse1-6. Human orthologs of 
Smc5 and 6 and of Nse1 and 2 have been identified previously by ourselves and 
others (8, 9, 24, 27).  Potts and Yu (24) extensively characterised hNSE2 (hMMS21), 
showing that, like S. pombe Nse2 (2), it is a SUMO ligase and is able to sumoylate 
hSMC6 when both hMMS21/hNSE2 and hSMC6 are overexpressed. In apparent 
contrast, our results in Figure 4B did not show an increase in sumoylation of hSMC5 
and hSMC6, when we overexpressed hMMS21/hNSE2. However, we analysed 
sumoylation of endogenous hSMC5 and 6, and we know that these proteins are 
entirely in the protein complex, including hMMS21/hNSE2. We might anticipate 
therefore that the associated SUMO ligase activity of hMMS21/hNSE2 has carried 
out the sumoylation of hSMC5 and 6 within the same molecule of complex. The 
apparent difference in our results and those of Potts and Yu can therefore be attributed 
to the analysis of overexpressed hSMC6 in their experiments and endogenous proteins 
in our experiments.  
 
Potts and Yu also reported that depletion of hMMS21/hNSE2 by siRNA sensitised 
HeLa cells to the toxic effects of MMS as measured by trypan blue exclusion and 
apoptosis. In subsequent work the same authors showed that depletion of 
hMMS21/hNSE2 increased gene targeting, had no effect on non-homologous end-
joining, but reduced the levels of sister chromatid exchanges induced by camptothecin 
and reduced the number of long-tract gene conversions. These data suggest that 
hMMS21/hNSE2 and by implication the hSMC5-6 complex is required for 
recombination between sisters but not between homologous chromosomes. 
hMMS21/hNSE2 is loaded onto chromatin at double-strand break sites and is required 
for loading cohesin at these sites (23). Our data show that not only hMMS21/hNSE2, 
but also endogenous hSMC5 and hSMC6 are sumoylated in vivo, and that hNSE1, 
hSMC5 and hSMC6 are ubiquitylated (Figures 4 and 5). The biological roles of these 
modifications remain to be determined.  
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 Using siRNA knockdowns, we have shown that all members of the complex with the 
exception of hMMS21/hNSE2 are required to maintain the stability of the complex. 
This is consistent with our previous finding that S. pombe Nse2 binds to the coiled 
coil domain of Smc5, whereas all other components bind at the heads of the SMC5-6 
structure (20, 26). In S. pombe, mutations in Smc5-6 components confer sensitivity to 
a wide range of DNA damaging agents. We found that depletion of hNSE1 and 
hNSE4a conferred sensitivity to MMS, but not to several other DNA-damaging 
agents, as measured by colony-forming activity (Figure 3D). So far, we have not 
observed similar sensitivity on depletion of other components. Although the levels of 
depletion appeared to be around 80%, we consider that the most likely reason for this 
apparent discrepancy is that for some of the depletions, sufficient amounts of the 
complex remained to carry out its function in response to MMS. In support of this 
suggestion, the depletions conferred by siRNA for hNSE1 and hNSE4a, which did 
confer sensitivity to MMS, appeared to be almost complete with residual protein 
barely detectable.  Taken together with the results of Potts et al (23, 24), we conclude 
that the human hSMC5-6 complex, like that of the yeasts, is involved in the response 
to DNA damage. It is hazardous to make definitive conclusions, when normal 
responses are obtained using siRNA approaches. We therefore consider it premature 
at this point to conclude that the sensitivity to a broad range of DNA damaging agents 
in yeast and the relatively narrow range of sensitivity that we have found in human 
cells represents a genuine mechanistic difference rather than a technical issue. Further 
work is necessary to resolve whether these differences are real or apparent. 
 
We used a proteomic approach to identify the two new components, the orthologs of 
Nse4 and Nse3, and have shown that all six components form a tight complex in 
human cells. We previously provided evidence that Nse4 is a member of the kleisin 
superfamily (25), which bridges the Smc5 and Smc6 globular heads (20). Structure 
prediction programs indicated that Nse4 and its orthologs had N-terminal helix-turn-
helix and C-terminal winged-helix motifs. The amino acids involved in these 
structural motifs are the most highly conserved sequences in the alignments of Nse4 
with the human orthologs, and both orthologs have these motifs (Figure 2A). 
Although both orthologs of Nse4 are capable of forming part of the complex, only 
hNSE4a is found in the endogenous complex in cultured cells. Whereas hNSE4a is 
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expressed in somatic cells, hNSE4b/EID3 is expressed only in testis and is an 
inhibitor of CBP-dependent co-activation of nuclear receptor-mediated transcription 
(4). Whether it fulfils this transcriptional function in a testis-specific form of the 
hSMC5-6 complex, and whether more generally there is a meiosis-specific form of 
the hSMC5-6 complex remains to be determined. 
 
We identified MAGEG1 as the ortholog of Nse3. The MAGE family has received 
much attention because members of the MAGE-A, B and C families (classified as 
Type I MAGE genes) are expressed exclusively in tumour cells and/or germ cells. 
The 12 members comprising the MAGE-D, E, F, G, H, L2 proteins and necdin are 
expressed in all tissues and have been designated Type II (3, 7). Individual members 
have been reported as playing roles in neuronal development, apoptosis and cell cycle 
control (reviewed in (3)). No biochemical function has been identified for any of the 
MAGE proteins. The MAGEG1/NDNL2 gene has been mapped close to the necdin 
and MAGEL2 genes near to the region deleted in Prader-Willi syndrome (PWS)(6). It 
was not subject to imprinting like nearby genes implicated in PWS, and therefore 
probably does not play a role in the aetiology of this disorder. The gene was expressed 
in all tissues, but like hSMC5 and 6 (27), most abundantly in testis (11). When 
transfected into cells, MAGEG1, like necdin, reduced cell proliferation, an effect 
possibly mediated by its interaction with the E2F1 transcriptional activator. 
Furthermore like necdin, MAGEG1 interacts with the p75 neurotrophin receptor and 
may be involved in brain development (11). Intriguingly, recent evidence suggests 
that only one MAGE gene exists in genomes from plants, nematodes, insects and even 
non-mammalian vertebrates (14). Like MAGEG1, the chicken MAGE protein 
interacts with E2F1 and the p75 neurotrophin receptor, and interestingly the 
Drosophila MAGE protein showed highest sequence identity to MAGEG1 and is 
highly expressed during postembryonic neurogenesis (19). 
 
We previously found a particularly strong interaction between S. pombe Nse3 and 
Nse1 (26), and it is likely that there is a similar interaction between hNSE1 and 
MAGEG1. Interestingly, our gel filtration analysis of Figure 3A suggests that all the 
other components of the SMC5-6 complex are located exclusively in the complex, 
whereas a proportion of HNSE1 and MAGEG1 eluted with a much lower molecular 
weight. One might speculate that this represents an hNSE1-MAGEG1 heterodimer.  It 
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would be interesting to determine if, during brain development, MAGEG1 functioned 
on its own, as a heterodimer with hNSE1 or as part of the SMC5-6 complex.  
 
Our finding that MAGEG1 and the yeast members of the family are essential 
components of the hSMC5-6 complex may provide a clue to the biochemical function 
of the MAGE family and may also point to an involvement of SMC5-6 in brain 
development. It is possible that as with the SMC5-6 complex, other mammalian 
MAGE proteins are part of protein complexes, where they provide interaction 
surfaces or platforms for other polypeptides. Our current efforts are directed towards 
resolving these issues. 
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Figure legends 
Fig. 1. Endogenous hNSE1 and hMMS21/hNSE2 co-immunoprecipitate with 
SMC6. 
(A) Alignment of the upstream sequences of  hNSE1 from several mammalian 
species. (B) Anti-hNSE1 antibody detects two major translation products (1a and 1b) 
on Western blots when hNSE1 is expressed in vitro from expression constructs 
including the complete ORF (Met2) or the ORF plus 5’ UTR sequence (Met1) (lanes 
1 and 2). Both protein products are also seen in MRC5V1 whole cell extracts (lane 3). 
To confirm the predicted start sites, the indicated methionines were mutated to alanine 
in the construct including the 5’UTR (Right panel). 
(C) and (E) HeLa nuclear extract was incubated with protein A sepharose coupled to 
either anti-hSMC6 or anti-hNSE1 antibodies or control rabbit IgGs. The non-bound 
(NB) and immunoprecipitated (IP) fractions were subsequently analysed by Western 
blotting with the indicated antibodies. * indicates a non-specific cross-reacting band. 
(D) Anti-hMMS21/hNSE2 antibodies detect the hMMS21/hNSE2 protein on Western 
blots when hMMS21/hNSE2 is expressed in vitro in reticulocyte lysate (lane 2) but 
not in control reticulocyte lysate (lane 1). An equivalent band is recognised in 
MRC5V1 cell extracts (lane 3). 
 
Fig. 2. FLAG-hNSE4a, FLAG-hNSE4b and MAGEG1 co-immunoprecipitate 
with hSMC6 and hNSE1. 
(A) Alignment of two human hNSE4 paralogs with S. pombe Nse4. (B-D) Anti-FLAG 
M2 antibody was used to immunoprecipitate FLAG-tagged proteins from whole cell 
extracts prepared from MRC5V1 control cells and stably transfected MRC5V1 cells 
expressing (B) FLAG-hNSE4a (F-N4a); (C) FLAG-hNSE4b (F-N4b) and (D) FLAG-
MAGEG1 (F-G1) and FLAG-MAGEF1 (F-F1). hSMC6, hNSE1 and FLAG-tagged 
proteins were detected in the extracts and in the immunoprecipitated fractions by 
Western blotting. 
 
Fig. 3. hSMC5 and hSMC6 form a stable complex with hNSE1, 
hMMS21/hNSE2, hNSE4a and MAGE-G1 that is required for survival following 
exposure to MMS. 
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(A) Protein A sepharose coupled to anti-hSMC6 or anti-hNSE1 antibodies was used 
to immunoprecipitate the hSMC5/6 complex from HeLa nuclear extract. Non-specific 
rabbit IgGs were used as a negative control. Immunoprecipitated complexes were 
washed in buffer containing 1M NaCl before Western blot analysis of the 
immunoprecipitated and non-bound fractions. 
(B) HeLa nuclear extract was applied to a Superdex 200 gel filtration column and 
fractions were analysed by Western blotting with antibodies to each of the hSMC5/6 
complex components. 
(C) MRC5V1 cells were transfected with a non-targeting control (NTC) siRNA or 
siRNAs specific to hSMC5, hNSE1, hMMS21/hNSE2, hNSE4a or MAGEG1. 72h 
after siRNA transfection whole cell extracts were prepared and protein expression 
levels were examined by immunoblotting with the antibodies indicated. 
(D) 96h after transfection with hNSE1, hNSE4a or non-targeting (NT) siRNAs 
MRC5V1 cells were treated with the indicated doses of MMS for 1h. Following 
removal of the drug cells were counted and plated for colony formation. Colonies 
were counted after 12 days and the % survival was determined relative to untreated 
cells for each transfected cell line (left hand panel). Results show means + SEM of at 
least three experiments. Whole cell extracts were prepared 96h post-transfection and 
protein levels were analysed by Western blotting with the indicated antibodies (right 
hand panel).  
 
Fig. 4. Sumoylation of hSMC5/6 complex components. 
(A) MRC5V1 cells were transfected with myc-hMMS21/hNSE2 along with SUMO1 
expression constructs (His-SUMO, GFP-SUMO and GFP-His-SUMO) or empty 
vector. 24h after transfection cells were lysed and the lysates were incubated with 
Ni2+-NTA agarose for 3h. Sumoylated forms of myc-hMMS21/hNSE2 were detected 
in the whole cell extracts and in the nickel pulldowns by Western blotting with anti-
hMMS21/hNSE2 antibody. 
(B) 24h after transfection of MRC5V1 cells with GFP-His-SUMO (or mock 
transfection) extracts were prepared and His-tagged proteins were captured on Ni2+-
NTA agarose. Sumoylated forms of hSMC5 and hSMC6 were detected in the nickel 
pulldowns by Western blotting with anti-hSMC5 and anti-hSMC6 antibodies. 
Treatment with 0.0075% MMS for 3h immediately prior to lysing the cells or co-
transfection with myc-hMMS21/hNSE2 had no effect on hSMC5/6 sumoylation. 
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 Fig. 5. Ubiquitylation of SMC5/6 complex components. 
(A) MRC5V1 cells were transfected with FLAG-hNSE1 and His-ubiquitin expression 
constructs, either singly or in combination. 24h after transfection the cells were lysed 
and His-tagged proteins were captured on Ni2+-NTA agarose. His-ubiquitylated 
FLAG-hNSE1 protein was detected on Western blot using anti-hNSE1 antibody. 
(B) Nickel pulldown from extracts prepared 24h post-transfection with His-ubiquitin 
(or mock transfected). Ubiquitylated forms of hNSE1 were detected by Western 
blotting with anti-hNSE1 antibody. 
(C) 24h after transfection of MRC5V1 cells with His-ubiquitin (or mock transfection) 
cells were either left untreated or were treated with 0.0075% MMS for 3h. Whole cell 
extracts were prepared and His-tagged proteins were captured on Ni2+-NTA agarose. 
Ubiquitylated forms of hSMC5 and hSMC6 were detected in the nickel pulldowns by 
Western blotting with anti-hSMC5 and anti-hSMC6 antibodies. 
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Table 1, siRNAs 
 
Protein SiRNA target sequence 
hNSE1 CCGGCTTTGCGTCTTCCACAA 
hMMS21/hNSE2 AACTCTGGTATGGACACAGCT 
MAGEG1 TAGGATGTGTTTGCAAAGTTT 
NSE4a CTCCTTTGACATGTTAAGATA 
hSMC5 AAGCGAAGAGAGAGGGAAACT 
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Table 2 
Mass spectrometric analysis of proteins copurifying with hNSE1 and hSMC6 
 
 hNSE1 purification hSMC6 purification 
Protein Number of 
peptides 
% coverage Number of 
peptides 
% coverage 
hSMC5 28 19.9 7 6.6 
hSMC6 21 23.5 8 8.4 
hNSE1 5 18.6   
hMMS21/hNSE2 5 19.0   
hNSE4a 6 17.1 2 8.1 
MAGEG1 4 17.9 3 3.5 
 
Anti-hNSE1 or anti-hSMC6 antibodies coupled to protein A sepharose were used to 
immunoprecipitate the indicated proteins from HeLa nuclear extract. Eluted 
complexes were analysed by mass spectrometry. The number of independent peptides 
of each protein recovered and the percentage of primary sequences covered by these 
peptides is presented. 
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